Xponance, Inc. Natera, Inc. Transaction History
Xponance, Inc.
- $10.2 Billion
- Q3 2024
A detailed history of Xponance, Inc. transactions in Natera, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 16,157 shares of NTRA stock, worth $2.72 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,157
Previous 15,704
2.88%
Holding current value
$2.72 Million
Previous $1.7 Million
20.76%
% of portfolio
0.02%
Previous 0.02%
Shares
16 transactions
Others Institutions Holding NTRA
# of Institutions
528Shares Held
119MCall Options Held
308KPut Options Held
191K-
Vanguard Group Inc Valley Forge, PA11.4MShares$1.93 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY6.77MShares$1.14 Billion0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY4.63MShares$780 Million0.05% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.56MShares$768 Million2.91% of portfolio
-
Fred Alger Management, LLC New York, NY4.01MShares$676 Million2.57% of portfolio
About Natera, Inc.
- Ticker NTRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 96,957,400
- Market Cap $16.3B
- Description
- Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...